Accepted for/Published in: JMIR Formative Research
Date Submitted: Oct 14, 2022
Date Accepted: Apr 6, 2023
Date Submitted to PubMed: Apr 6, 2023
The user experience of a mobile medication support application and its impact on medication compliance for people living with HIV: Results of a 12-week pilot study
ABSTRACT
Background:
Continuity of care between hospital visits through mobile application (app) creates new opportunities for people living with HIV (PLWH) in situations where face-to-face interventions are difficult.
Objective:
This study investigated the user satisfaction of a mobile health support app aimed to improve anti-retroviral therapy (ART) adherence and facilitate tele-consultation between PLWH and medical staff.
Methods:
PLWH and medical staff from two clinics in Japan were invited to participate in a 12-week trial of the medication support app between July 27, 2018 and March 31, 2021.
Results:
A total of 10 PLWH and 11 medical staff were included in this study. During the trial, the medication compliance rate was 90%, and the mean response rates to symptom and medication alerts were 73% and 76%, respectively. Overall, 81% of PLWH users and 65% of medical staff were satisfied. The ability to alert and track medications taken was found most useful by both PLWH users and medical staff.
Conclusions:
Our preliminary results demonstrate that this medication support app prototype assists medication adherence and enhances communication between PLWH and medical staff.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.